Literature DB >> 4876731

Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum.

K H Rieckmann, J V McNamara, H Frischer, T A Stockert, P E Carson, R D Powell.   

Abstract

Studies with 3 volunteers were conducted to determine the effects of a combination of sulfadiazine and pyrimethamine and the effects of primaquine upon mature gametocytes of a strain of chloroquine-resistant Plasmodium falciparum-the Malayan (Camp.) strain. One volunteer was treated with sulfadiazine and pyrimethamine; two other volunteers each received a single dose of 45 mg of primaquine base. The combination of sulfadiazine and pyrimethamine, although active against blood schizonts, did not exert a marked sporontocidal effect against the Malayan (Camp.) strain. In sharp contrast, primaquine, although not effective as a blood schizontocide, exerted a marked gametocytocidal and sporontocidal effect against this strain.The findings emphasize the need for further studies of the sporontocidal and gametocytocidal effects of drugs, particularly primaquine, against chloroquine-resistant strains of P. falciparum and suggest that primaquine may come to play an important role in preventing the transmission of such strains.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4876731      PMCID: PMC2554527     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  9 in total

1.  ANTIMALARIAL DRUG TRIALS ON A MULTIRESISTANT STRAIN OF PLASMODIUM FALCIPARUM.

Authors:  G M JEFFERY; W E COLLINS; J C SKINNER
Journal:  Am J Trop Med Hyg       Date:  1963-11       Impact factor: 2.345

2.  The treatment of Plasmodium falciparum infection with chloroquine, with a note on infectivity to mosquitoes of primaquine- and pyrimethamine-treated cases.

Authors:  G M JEFFERY; M D YOUNG; D E EYLES
Journal:  Am J Hyg       Date:  1956-07

3.  PROCEDURES USED AT STATEVILLE PENITENTIARY FOR THE TESTING OF POTENTIAL ANTIMALARIAL AGENTS.

Authors:  A S Alving; B Craige; T N Pullman; C M Whorton; R Jones; L Eichelberger
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

4.  Sulphormethoxine in chloroquine-resistant falciparum malaria in Thailand.

Authors:  T Harinasuta; C Viravan; H A Reid
Journal:  Lancet       Date:  1967-05-27       Impact factor: 79.321

5.  The evaluation of sulfonamides, alone or in combination with pyrimethamine, in the treatment of multi-resistant falciparum malaria.

Authors:  W Chin; P G Contacos; G R Coatney; H K King
Journal:  Am J Trop Med Hyg       Date:  1966-11       Impact factor: 2.345

6.  Clinical experience with sulphadiazine and pyrimethamine in the treatment of persons experimentally infected with chloroquine-resistant Plasmodium falciparum.

Authors:  R D Powell; R L DeGowin; J V McNamara
Journal:  Ann Trop Med Parasitol       Date:  1967-12

7.  Combined therapy for chloroquine-resistant, Plasmodium falciparum infection. Concurrent use of long-acting sulphormethoxine and pyrimethamine.

Authors:  P J Bartelloni; T W Sheehy; W D Tigertt
Journal:  JAMA       Date:  1967-01-16       Impact factor: 56.272

8.  STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM THAILAND.

Authors:  R D POWELL; G J BREWER; A S ALVING; J W MILLAR
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

9.  The effect of a single dose of primaquine on the gametocytes, gametogony and sporogony of Laverania falciparum.

Authors:  R W BURGESS; R S BRAY
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

  9 in total
  31 in total

1.  Transmission-blocking activities of quinine, primaquine, and artesunate.

Authors:  Kesinee Chotivanich; Jetsumon Sattabongkot; Rachanee Udomsangpetch; Sornchai Looareesuwan; Nicholas P J Day; Russell E Coleman; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Effect of the 8-aminoquinoline primaquine on culture-derived gametocytes of the malaria parasite Plasmodium falciparum.

Authors:  H N Lanners
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

3.  Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates.

Authors:  M J Portela; R Moreira; E Valente; L Constantino; J Iley; J Pinto; R Rosa; P Cravo; V E do Rosário
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

4.  Tropical splenomegaly syndrome.

Authors:  K H Rieckmann
Journal:  Br Med J       Date:  1970-10-17

5.  Pharmacology of 8-aminoquinolines.

Authors:  R S Grewal
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

Review 6.  Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.

Authors:  Rashad Abdul-Ghani; John C Beier
Journal:  Parasitol Res       Date:  2014-09-04       Impact factor: 2.289

7.  Appropriate time for primaquine treatment to reduce Plasmodium falciparum transmission in hypoendemic areas.

Authors:  Polrat Wilairatana; Srivicha Krudsood; Noppadon Tangpukdee
Journal:  Korean J Parasitol       Date:  2010-06-17       Impact factor: 1.341

8.  Reinventing primaquine for endemic malaria.

Authors:  John Kevin Baird
Journal:  Expert Opin Emerg Drugs       Date:  2012-09-21       Impact factor: 4.191

Review 9.  Controlled Human Malaria Infection: Applications, Advances, and Challenges.

Authors:  Danielle I Stanisic; James S McCarthy; Michael F Good
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

10.  Single-Dose Primaquine in a Preclinical Model of Glucose-6-Phosphate Dehydrogenase Deficiency: Implications for Use in Malaria Transmission-Blocking Programs.

Authors:  Kristina S Wickham; Paul C Baresel; Sean R Marcsisin; Jason Sousa; Chau T Vuong; Gregory A Reichard; Brice Campo; Babu L Tekwani; Larry A Walker; Rosemary Rochford
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.